Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia
Sickle cell disease (SCD) is a group of related yet genetically complex hemoglobinopathies. Universal newborn screening (NBS) for SCD is performed in the United States and many other nations. Classical, protein-based laboratory methods are often adequate for the diagnosis of SCD but have specific li...
Saved in:
Main Authors: | Lisa M. Shook, Deidra Haygood, Charles T. Quinn |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c1f70e7f65144aefa23176d0bb39f992 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variantes de hemoglobina en una población con impresión diagnóstica positiva para hemoglobinopatías en Colombia
by: Romero-Sánchez,Consuelo, et al.
Published: (2015) -
Sickle Cell Anemia and <i>Babesia</i> Infection
by: Divya Beri, et al.
Published: (2021) -
Screening for the Sickle Cell Trait in Odisha, India: An Approach to a Major Public Health Burden
by: Basanta Kumar Bindhani, et al.
Published: (2021) -
Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
by: Parmod K. Bithal, et al.
Published: (2021) -
In Vitro Red Blood Cell Segregation in Sickle Cell Anemia
by: Viviana Clavería, et al.
Published: (2021)